Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P980016/S965

Cobalt MRI ICD, Cobalt XT MRI ICD, Crome MRI ICD

Medtronic Cardiac Rhythm Disease Management · Decision date Sep 25, 2026

MEDTECHLEDGER EXPLANATIONP980016/S965

What did the FDA decide?

FDA database entry P980016/S965 records a 30-day notice for the Cobalt MRI ICD, Cobalt XT MRI ICD, and Crome MRI ICD. The stated purpose is updates to visual inspection criteria for anode components at the Medtronic Energy and Component Center (MECC). The supplement type is a 30-Day Notice, and the supplement reason is listed as a process change involving manufacturer, sterilizer, packager, or supplier.

This entry does not represent a new approval of the device system. The original PMA identifier P980016 establishes the parent application, while S965 is a supplement limited to the described manufacturing process change. The source statement reports the intended scope of the notice; it does not independently demonstrate safety or clinical effectiveness. Specific details about what the updated inspection criteria require are not present in the available fields.

FDA approval order statement

updates to visual inspection criteria for anode components at the Medtronic Energy and Component Center (MECC)
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Cardiovascular
Decision date
Sep 25, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P980016/S965
Regulatory pathway
PMA supplement
Product code
LWS
Decision code
OK30
Decision date
Sep 25, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Implantable cardioverter defibrillator (non-CRT).

Product code
LWS
FDA device class
3

For the original device and its historical approval scope, see PMA P980016. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P980016 · Original PMA

    VIRTUSO/ENTRUST/MAXIMO/INTRINSIC/MARQUIS/IMPLANTABLE CARDIVERTER DEFIBRILLATORS

  2. P980016/S965 received

    Application receipt date recorded by FDA.

  3. P980016/S965 · FDA decision

    30-Day Notice

  4. P980016/S966 · Related supplement

    Cobalt MRI ICD (DDPB3Dl, DDPB3D4, DVPB3Dl, DVPB3D4); Cobalt XT MRI ICD (DDPA2Dl, DDPA2D4, DVPA2Dl, DVPA2D4); Crome MRI I

  5. P980016/S967 · Related supplement

    Cobalt MRI ICD, Cobalt XT MRI ICD, Crome MRI ICD

  6. P980016/S964 · Related supplement

    Cobalt MRI ICD (DDPB3D1, DDPB3D4, DVPB3D1, DVPB3D4); Cobalt XT MRI ICD (DDPA2D1, DDPA2D4, DVPA2D1, DVPA2D4); Crome MRI I

Timeline entries are records held by MedtechLedger for P980016. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P980016

Explore the linked device profile

Other records with product code LWS

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Medtronic Cardiac Rhythm Disease Management

Headquarters
Not reported
Brand website
medtronic.com
FDA applicant address
8200 Coral Sea St. N.E, Ms Mvs11, Mounds View, MN, 55112

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records